We propose that the combination of immune tolerance to insulin [5, 6] and preserved beta cell function [9] in patients carrying the protective INS variant contributes to superior glycemic control previously reported in carriers with recent onset pediatric T1D, thereby reducing the risk of development of diabetic complications. This evidence concerns the gene INS and type 1 diabetes mellitus.